These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11967391)

  • 1. Frequency and costs of ischemic and bleeding complications after percutaneous coronary interventions: rationale for new antithrombotic agents.
    Moscucci M
    J Invasive Cardiol; 2002 Apr; 14 Suppl B():55B-64B. PubMed ID: 11967391
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of bleeding and blood transfusion in percutaneous coronary intervention.
    Rao SV
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S18-26. PubMed ID: 17917617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice.
    Doyle BJ; Rihal CS; Gastineau DA; Holmes DR
    J Am Coll Cardiol; 2009 Jun; 53(22):2019-27. PubMed ID: 19477350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of payment in Thai acute coronary syndrome patients.
    Moleerergpoom W; Kanjanavanit R; Jintapakorn W; Sritara P
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():21-31. PubMed ID: 18431883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stents, antithrombotic agents and vascular complications. Does site of arterial access make a difference?
    Emanuelsson H
    Eur Heart J; 2000 Apr; 21(8):607-9. PubMed ID: 10731396
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
    Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
    Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cost analysis of two different medical interventions: educational implications.
    Platis H; Liaropoulos L
    Stud Health Technol Inform; 1998; 51():50-64. PubMed ID: 10179635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
    Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
    Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding complications with PCI.
    Satler LF
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):373-4. PubMed ID: 15736243
    [No Abstract]   [Full Text] [Related]  

  • 12. eComment: Costs of percutaneous coronary intervention versus coronary artery bypass surgery.
    Almeida RM
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):672. PubMed ID: 19443497
    [No Abstract]   [Full Text] [Related]  

  • 13. Transradial intervention for minimizing bleeding complications in percutaneous coronary intervention.
    Hamon M; Coutance G
    Am J Cardiol; 2009 Sep; 104(5 Suppl):55C-9C. PubMed ID: 19695363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Direct and indirect treatment cost of patient with ischaemic heart disease].
    Maciag A; Wysocki MJ; Bak MI
    Przegl Epidemiol; 2008; 62(3):669-76. PubMed ID: 19108532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Easing the economic burden of acute coronary syndromes: cost-effectiveness of emerging therapies.
    Nutescu EA
    Am J Manag Care; 2006 Dec; 12(16 Suppl):S444-50. PubMed ID: 17203989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
    Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
    Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of recent US cost estimates of revascularization.
    Nagle PC; Smith AW
    Am J Manag Care; 2004 Oct; 10(11 Suppl):S370-6. PubMed ID: 15603246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous intervention versus coronary bypass surgery for patients older than 70 years of age with high-risk unstable angina.
    Ramanathan KB; Weiman DS; Sacks J; Morrison DA; Sedlis S; Sethi G; Henderson WG
    Ann Thorac Surg; 2005 Oct; 80(4):1340-6. PubMed ID: 16181866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
    Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.